(Q38617129)

4 September 2017

1 reference

title

Renal vascular and thrombotic effects of cyclosporine (English)

1 reference

4 September 2017

1

1 reference

4 September 2017

Bertani T

2

1 reference

4 September 2017

publication date

1 April 1989

1 reference

American Journal of Kidney Diseases

4 September 2017

published in

1 reference

4 September 2017

volume

13

1 reference

4 September 2017

issue

4

1 reference

4 September 2017

page(s)

261-272

1 reference

Nephrotoxicity of cyclosporin A in bone-marrow transplantation

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Use of cyclosporin a despite renal dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

A toxicological study in rats receiving immunotherapeutic doses of cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Bone marrow transplantation in severe aplastic anaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Nephrotoxicity in bone marrow transplant recipients treated with cyclpsporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine-associated renal arteriopathy resulting in loss of allograft function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Hemolytic uremic syndrome in renal allografted patients treated with cyclosporin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation--successful treatment with plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Vascular lesions as manifestations of cyclosporin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

An analysis of cyclosporine efficacy and toxicity after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Effect of cyclosporine administration on renal hemodynamics in conscious rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

The effect of salt intake on cyclosporine-induced impairment of renal function in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

The haemodynamic effects of cyclosporin A in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Arachidonic acid metabolism, prostaglandins and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Is cyclosporin toxic to endothelial cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Glomerular thrombi in renal allografts associated with cyclosporin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporin relieves arthralgia, causes angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine: Five Years' Experience in Cadaveric Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cardiovascular function in nonarteriosclerotic versus arteriosclerotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

Cyclosporine toxicity on cultured rat microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980032-0

7 January 2021

10.1016/S0272-6386(89)80032-0

Identifiers

DOI

1 reference

4 September 2017

1 reference